FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jurriën ten Berg

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Devices

Stents

Disorders

Anatomy

Physiology

Platelet Aggregation

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Paul W A Janssen; Jurriën M ten Berg
Platelet function testing and tailored antiplatelet therapy.
J Van Der Heyden; D Van Neerven; J Van Werkum; Jan Albert Vos; F Wolters; S C Tromp; R G A Ackerstaff; N J Breet; Jean-Paul P M de Vries; Vera H M Deneer; E H A Elsenberg; Christian M Hackeng; Johannes C Kelder; W J Schonewille; Maarten J Suttorp; Jurriën M ten Berg
High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial.
Gilles Montalescot; Johanne SILVAIN; Jurriën M ten Berg; Anne Tsatsaris; Warren J Cantor; Shaun G Goodman; Christian W Hamm; Frédéric Lapostolle; Jens Flensted Lassen; Muriel Licour; Arnoud W van't Hof
Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jurriën ten Berg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Paul W A Janssen; Jurriën M ten Berg
Platelet function testing and tailored antiplatelet therapy.
Journal of cardiovascular translational research 2013;6(3):316-28.
2013: J Van Der Heyden; D Van Neerven; J Van Werkum; Jan Albert Vos; F Wolters; S C Tromp; R G A Ackerstaff; N J Breet; Jean-Paul P M de Vries; Vera H M Deneer; E H A Elsenberg; Christian M Hackeng; Johannes C Kelder; W J Schonewille; Maarten J Suttorp; Jurriën M ten Berg
High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial.
The Journal of cardiovascular surgery 2013;54(3):337-47.
2013: Gilles Montalescot; Johanne SILVAIN; Jurriën M ten Berg; Anne Tsatsaris; Warren J Cantor; Shaun G Goodman; Christian W Hamm; Frédéric Lapostolle; Jens Flensted Lassen; Muriel Licour; Arnoud W van't Hof
Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study.
American heart journal 2013;165(4):515-22.
2013: Willem J M Dewilde; Antonius A C M Heestermans; Jean-Paul Herrman; Johannes C Kelder; Tom Oirbans; Jurriën M ten Berg; Jan G P Tijsen; Arnoud W van 't Hof; Freek W A Verheugt; Marije M Vis; Mathias Vrolix; Tom Adriaenssens; Bart J G L de Smet
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.
Lancet 2013;381(9872):1107-15.
2013: Thomas O Bergmeijer; Robert A Lichtveld; Sonja Postma; Arnoud Wj Van't Hof; Jurriën M ten Berg
Prehospital treatment of ST-segment elevated myocardial infarction patients.
Future cardiology 2013;9(2):229-41.
2012: Patrick Houthuizen; Jolanda Kluin; Jos G Maessen; Thomas T Poels; Martin H Prins; Jan Baan; Mohamed Bentala; Guus R G Brueren; Ricardo Cocchieri; Peter de Jaegere; Peter den Heijer; Martin J Schalij; Pieter R Stella; Ben M Swinkels; Jurriën M ten Berg; Robert M A van der Boon; Frank van der Kley; Leen A F M Van Garsse; Vincent Van Ommen; Albert H M van Straten; Frits W Prinzen
Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death.
Circulation 2012;126(6):720-8.
2012: Jurriën M ten Berg; Vera H Deneer
Antiplatelet therapy: Does CYP2C19 genotype affect clinical outcome?
Nature reviews. Cardiology 2012;9(4):192-4.
2012: Thomas O Bergmeijer; Jurriën M ten Berg
Value of CYP2C19 *2 and *17 genotyping in clinical practice. Promising but not ready yet.
Revista española de cardiología (English ed.) 2012;65(3):205-7.
2012: Ankie M Harmsze; Johannes C Kelder; Olaf H Klungel; Henk Ruven; Jurriën M ten Berg; Jochem W van Werkum; Heleen J Bouman; Nicoline J Breet; Anthonius de Boer; Christian M Hackeng; Vera H M Deneer
The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting.
Pharmacogenetics and genomics 2012;22(3):169-75.
2012: Ben J L Van den Branden; Jurriën M ten Berg; Johannes C Kelder; Gert-Jan Laarman; Braim M Rahel; Ton Slagboom; Maarten J Suttorp
Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study).
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2012;7(10):1189-96.
2011: N J Breet; Christian M Hackeng; A M Harmsze; Johannes C Kelder; M A Sluman; M A J P J van Berkel; Jochem W van Werkum; F Zijlstra; H J Bouman; Jurriën M ten Berg
Effect of gender difference on platelet reactivity.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2011;19(11):451-7.
2011: A M Harmsze; O H Klungel; Henk Ruven; Patrick C Souverein; Jurriën M ten Berg; Jochem W van Werkum; H J Bouman; N J Breet; A de Boer; Christian M Hackeng; Vera H M Deneer
Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention.
Journal of thrombosis and haemostasis : JTH 2011;9(10):1892-901.
2011: Bas T G van der Lienden; Thom L de Kroon; Robin H Heijmen; E Gijs Mast; Ben M Swinkels; Jurriën M ten Berg
First valve-in-valve direct transaortic CoreValve implantation in an insufficient Sapien valve.
JACC. Cardiovascular interventions 2011;4(9):1049-50.
2011: Ton Heestermans; Petra Koopmans; Arend Mosterd; Jurriën M ten Berg; Gert van Houwelingen; Jan-Henk E Dambrink; Menko Jan de Boer; A T Marcel Gosselink; Christian Hamm; Jochem W van Werkum; Felix Zijlstra; Arnoud W J van 't Hof
Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2011;7(4):442-8.
2011: Heleen J Bouman; Nicoline J Breet; Vera H M Deneer; Christian M Hackeng; Ankie M Harmsze; Hugo Ten Cate; Jochem W van Werkum; Th O Bergmeijer; Jurriën M ten Berg
Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting.
Heart (British Cardiac Society) 2011;97(15):1239-44.
2011: Alexander Hirsch; Robert J Nijveldt; Jan J Piek; Jurriën M ten Berg; Jan G P Tijssen; René A Tio; Willem J van der Giessen; Pieter A van der Vleuten; Albert C van Rossum; Johannes Waltenberger; Felix Zijlstra; Jaap-Jan Zwaginga; Wim R M Aengevaeren; Bart J Biemond; Pieter A Doevendans
Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
European heart journal 2011;32(14):1736-47.
2011: Justin G Luermans; Herbert W Plokker; Maarten J Suttorp; Jurriën M ten Berg; Werner Budts; Martijn C Post
Comparison of outcome after patent foramen ovale closure in older versus younger patients.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2011;7(2):209-15.
2011: R C Steggerda; Jippe C Balt; Jurriën M ten Berg
Optimal gradient reduction after alcohol septal ablation: a case report with anatomical and practical determinants.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2011;19(6):301-3.
2011: Jurriën M ten Berg
Error in a study of the comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary artery stent implantation.
JAMA : the journal of the American Medical Association 2011;305(21):2172-3.
2011: B M Swinkels; Johannes C Kelder; H W M Plokker; Wim-Jan van Boven; F E E Vermeulen; Jurriën M ten Berg
Predicting 30-day mortality of aortic valve replacement by the AVR score.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2011;19(6):273-8.
2011: N J Breet; Christian M Hackeng; Johannes C Kelder; H E van Donkersgoed; Jochem W van Werkum; F Zijlstra; H J Bouman; Jurriën M ten Berg
Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an increased bleeding risk?
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2011;19(6):279-84.
2011: Nicoline J Breet; Jochem W van Werkum; Heleen J Bouman; Johannes C Kelder; Ankie M Harmsze; Christian M Hackeng; Jurriën M ten Berg
High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention.
Heart (British Cardiac Society) 2011;97(12):983-90.
2011: Ben J L Van Den Branden; Jurriën M ten Berg; H W M Plokker; Martijn C Post; Maarten J Suttorp
Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety.
Journal of interventional cardiology 2011;24(3):264-70.
2011: Stefan A J Timmer; Tjeerd Germans; Marco J W Götte; Iris Rüssel; Mark Lubberink; Jurriën M ten Berg; Folkert J Ten Cate; Adriaan A Lammertsma; Paul Knaapen; Albert C van Rossum
Relation of coronary microvascular dysfunction in hypertrophic cardiomyopathy to contractile dysfunction independent from myocardial injury.
The American journal of cardiology 2011;107(10):1522-8.
2011: H J Bouman; Jochem W van Werkum; N J Breet; H ten Cate; Christian M Hackeng; Jurriën M ten Berg
A case-control study on platelet reactivity in patients with coronary stent thrombosis.
Journal of thrombosis and haemostasis : JTH 2011;9(5):909-16.
2011: Koen Teeuwen; Bastiaan Zwart; Jochem W van Werkum; Michael Joner; Jurriën M ten Berg
3-dimensional optical coherence tomography imaging in early coronary stent thrombosis.
JACC. Cardiovascular interventions 2011;4(2):256-7.
2011: Bas J M Peters; Ankie M Harmsze; Jurriën M ten Berg; Anke Hilse Maitland-van der Zee; Mathieu M Tjoeng; Anthonius de Boer; Vera H M Deneer
CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel.
Pharmacogenomics 2011;12(2):141-4.
2011: Tim Bauer; Heleen J Bouman; Neville F Ford; Jurriën M ten Berg; Jochem W van Werkum; Dirk Taubert
Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.
BMJ (Clinical research ed.) 2011;343():d4588.
2011: Bastiaan Zwart; Jochem W van Werkum; Antonius A C M Heestermans; Johannes C Kelder; A Carla Zomer; Arnoud W J van 't Hof; Freek W A Verheugt; Jurriën M ten Berg
Triggering mechanisms of stent thrombosis.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2011;6(6):722-8.
2011: Heleen J Bouman; Edgar Schömig; Jochem W van Werkum; Janna Velder; Christian M Hackeng; Christoph Hirschhäuser; Christopher Waldmann; Hans-Günther Schmalz; Jurriën M ten Berg; Dirk Taubert
Paraoxonase-1 is a major determinant of clopidogrel efficacy.
Nature medicine 2011;17(1):110-6.
2011: Ton Heestermans; Harry Suryapranata; Jurriën M ten Berg; Arend Mosterd; A T Marcel Gosselink; Waclav Kochman; Thorsten Dill; Gert van Houwelingen; Evelien Kolkman; Jochem W van Werkum; Felix Zijlstra; Christian Hamm; Arnoud W J van 't Hof
Facilitated reperfusion with prehospital glycoprotein IIb/IIIa inhibition: predictors of complete ST-segment resolution before primary percutaneous coronary intervention in the On-TIME 2 trial: correlates of reperfusion before primary PCI.
Journal of electrocardiology 2011;44(1):42-8.
2011: Jochem W van Werkum; Jurriën M ten Berg
Platelet reactivity over time: solid as a rock or not durable?
Thrombosis and haemostasis 2011;105(1):3-4.
2011: R S Hermanides; A A C M Heestermans; Jurriën M ten Berg; A T Marcel Gosselink; Jan Paul Ottervanger; K G van Houwelingen; J J E Kolkman; P R Stella; T Dill; C Hamm; A W J van 't Hof
High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial.
Heart (British Cardiac Society) 2011;97(2):106-11.
2011: Nicoline J Breet; Jochem W van Werkum; Heleen J Bouman; Johannes C Kelder; Jurriën M ten Berg; Christian M Hackeng
Both peak and late aggregation are capable of identifying patients at risk for atherothrombotic events.
Thrombosis and haemostasis 2011;105(1):197-9.
2010: A A C M Heestermans; R S Hermanides; A T Marcel Gosselink; Menko Jan de Boer; J C A Hoorntje; H Suryapranata; Jan Paul Ottervanger; J-H E Dambrink; E Kolkman; Jurriën M ten Berg; Felix Zijlstra; A W J van 't Hof
A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI: Insights from the Zwolle acute myocardial infarction registry.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2010;18(12):592-7.
2010: Ton Heestermans; Arnoud W J van 't Hof; Jurriën M ten Berg; Jochem W van Werkum; Eric Boersma; Arend Mosterd; Pieter R Stella; Arthur B van Zoelen; A T Marcel Gosselink; Waclav Kochman; Thorsten Dill; Petra C Koopmans; Gert van Houwelingen; Felix Zijlstra; Christian Hamm
The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy.
American heart journal 2010;160(6):1079-84.
2010: Ankie M Harmsze; Jochem W van Werkum; Jurriën M ten Berg; Bastiaan Zwart; Heleen J Bouman; Nicoline J Breet; Arnoud W J van 't Hof; Henk Ruven; Christian M Hackeng; Olaf Klungel; Anthonius de Boer; Vera H M Deneer
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.
European heart journal 2010;31(24):3046-53.
2010: A A C M Heestermans; R S Hermanides; A T Marcel Gosselink; Menko Jan de Boer; J C A Hoorntje; H Suryapranata; Jan Paul Ottervanger; J-H E Dambrink; E Kolkman; Jurriën M ten Berg; Felix Zijlstra; A W J van 't Hof
A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI : Insights from the Zwolle acute myocardial infarction registry.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2010;18(12):592-7.
2010: Justin G L M Luermans; Martijn C Post; Jurriën M ten Berg; H W Thijs Plokker; Maarten J Suttorp
Long-term outcome of percutaneous closure of secundum-type atrial septal defects in adults.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2010;6(5):604-10.
2010: Jaap Jan J Smit; Jochem W van Werkum; Jurriën M ten Berg; Robbert Slingerland; Jan Paul Ottervanger; Ton Heestermans; Thorsten Dill; Christian Hamm; Arnoud W J van 't Hof
Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy.
Heart (British Cardiac Society) 2010;96(22):1815-20.
2010: A A C M Heestermans; Jochem W van Werkum; B Zwart; J A van der Heyden; Johannes C Kelder; N J Breet; A W J van't Hof; J-H E Dambrink; J J Koolen; B R G Brueren; Felix Zijlstra; Jurriën M ten Berg
Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome.
Journal of thrombosis and haemostasis : JTH 2010;8(11):2385-93.
2010: Adriaan A Voors; Anne M S Belonje; Felix Zijlstra; Hans L Hillege; Stefan D Anker; Riemer H J A Slart; René A Tio; Arnoud W J van 't Hof; J Wouter Jukema; Hans Otto J Peels; José P S Henriques; Jurriën M ten Berg; Jeroen Vos; Wiek H van Gilst; Dirk J van Veldhuisen
A single dose of erythropoietin in ST-elevation myocardial infarction.
European heart journal 2010;31(21):2593-600.
2010: N J Breet; Jochem W van Werkum; H J Bouman; Johannes C Kelder; Jurriën M ten Berg; Christian M Hackeng
High on-aspirin platelet reactivity as measured with aggregation-based, cyclooxygenase-1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events.
Journal of thrombosis and haemostasis : JTH 2010;8(10):2140-8.
2010: N J Breet; Jochem W van Werkum; H J Bouman; Johannes C Kelder; Jurriën M ten Berg; Christian M Hackeng
Do not adjust the platelet count in light transmittance aggregometry when predicting thrombotic events after percutaneous coronary intervention.
Journal of thrombosis and haemostasis : JTH 2010;8(10):2326-8.
2010: Ben J Van den Branden; Justin G Luermans; Martijn C Post; Herbert W Plokker; Jurriën M ten Berg; Maarten J Suttorp
The BioSTAR(r) device versus the CardioSEAL(r) device in patent foramen ovale closure: comparison of mid-term efficacy and safety.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2010;6(4):498-504.
2010: Ben J Van den Branden; Martijn C Post; Herbert W Plokker; Jurriën M ten Berg; Maarten J Suttorp
Patent foramen ovale closure using a bioabsorbable closure device: safety and efficacy at 6-month follow-up.
JACC. Cardiovascular interventions 2010;3(9):968-73.
2010: Jochem W van Werkum; Heleen J Bouman; Nicoline J Breet; Jurriën M ten Berg; Christian M Hackeng
The Cone-and-Plate(let) analyzer is not suitable to monitor clopidogrel therapy: a comparison with the flowcytometric VASP assay and optical aggregometry.
Thrombosis research 2010;126(1):44-9.
2010: Jurriën M ten Berg; Arnoud W J van 't Hof; Thorsten Dill; Ton Heestermans; Jochem W van Werkum; Arend Mosterd; Gert van Houwelingen; Petra C Koopmans; Pieter R Stella; Eric Boersma; Christian Hamm
Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome.
Journal of the American College of Cardiology 2010;55(22):2446-55.
2010: Nicoline J Breet; Jurriën M ten Berg; Jochem W van Werkum; Heleen J Bouman; Christian M Hackeng
Platelet function tests for the monitoring of P2Y12 inhibitors.
Expert opinion on medical diagnostics 2010;4(3):251-65.
2010: Ankie M Harmsze; Karen Robijns; Jochem W van Werkum; Nicoline J Breet; Christian M Hackeng; Jurriën M ten Berg; Henk Ruven; Olaf Klungel; Anthonius de Boer; Vera H M Deneer
The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
Thrombosis and haemostasis 2010;103(5):920-5.
2010: S A J Timmer; Mark Lubberink; Tjeerd Germans; Marco J W Götte; Jurriën M ten Berg; Folkert J Ten Cate; Albert C van Rossum; Adriaan A Lammertsma; Paul Knaapen
Potential of [11C]acetate for measuring myocardial blood flow: Studies in normal subjects and patients with hypertrophic cardiomyopathy.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2010;17(2):264-75.
2010: Jochem W van Werkum; Marjolein Kleibeuker; Sonja Postma; Heleen J Bouman; Ellen H A M Elsenberg; Jurriën M ten Berg; Christian M Hackeng
A comparison between the Plateletworks-assay and light transmittance aggregometry for monitoring the inhibitory effects of clopidogrel.
International journal of cardiology 2010;140(1):123-6.
2010: H J Bouman; E Parlak; Jochem W van Werkum; N J Breet; H ten Cate; Christian M Hackeng; Jurriën M ten Berg; D Taubert
Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel.
Journal of thrombosis and haemostasis : JTH 2010;8(3):482-8.
2010: Nicoline J Breet; Jochem W van Werkum; Heleen J Bouman; Johannes C Kelder; Henk Ruven; Egbert T Bal; Vera H M Deneer; Ankie M Harmsze; Jan A S van der Heyden; Benno J Rensing; Maarten J Suttorp; Christian M Hackeng; Jurriën M ten Berg
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
JAMA : the journal of the American Medical Association 2010;303(8):754-62.
2010: H J Bouman; Jochem W van Werkum; G Rudez; F W G Leebeek; Adrian Kruit; Christian M Hackeng; Jurriën M ten Berg; M P M de Maat; Henk Ruven
The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor.
Thrombosis and haemostasis 2010;103(2):379-86.
2010: Bastiaan Zwart; Jochem W van Werkum; A A C M Heestermans; Jurriën M ten Berg
Coronary stent thrombosis in the current era: challenges and opportunities for treatment.
Current treatment options in cardiovascular medicine 2010;12(1):46-57.
2010: Ankie Harmsze; Jochem W van Werkum; Heleen J Bouman; Henk Ruven; Nicolien J Breet; Jurriën M ten Berg; Christian M Hackeng; Mathieu M Tjoeng; Olaf Klungel; Anthonius de Boer; Vera H M Deneer
Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation.
Pharmacogenetics and genomics 2010;20(1):18-25.
2010: Bastiaan Zwart; Tjitske C Van Kerkvoorde; Jochem W van Werkum; Nicoline J Breet; Jurriën M ten Berg; Arnoud W J van 't Hof
Vigorous exercise as a triggering mechanism for late stent thrombosis: A description of three cases.
Platelets 2010;21(1):72-6.
2010: Justin G L M Luermans; Willem Jan Bos; Martijn C Post; Jurriën M ten Berg; HW Thijs Plokker; Maarten J Suttorp
Haemodynamic effects of patent foramen ovale and atrial septal defect closure: a comparison during percutaneous shunt closure.
Clinical physiology and functional imaging 2010;30(1):64-8.
2009: Justin G L M Luermans; Martijn C Post; Frederik Temmerman; Vincent Thijs; Wouter J Schonewille; H W M Plokker; Jurriën M ten Berg; Maarten J Suttorp; Werner Budts
Is a predominant left-to-right shunt associated with migraine?: A prospective atrial septal defect closure study.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;74(7):1078-84.
2009: Goran Rudez; Heleen J Bouman; Jochem W van Werkum; Frank W G Leebeek; Adrian Kruit; Henk Ruven; Jurriën M ten Berg; Moniek P M de Maat; Christian M Hackeng
Common variation in the platelet receptor P2RY12 gene is associated with residual on-clopidogrel platelet reactivity in patients undergoing elective percutaneous coronary interventions.
Circulation. Cardiovascular genetics 2009;2(5):515-21.
2009: A A C M Heestermans; J W Van Werkum; C Hamm; T Dill; A T M Gosselink; M J De Boer; G Van Houwelingen; J C A Hoorntje; P C Koopmans; Jurriën M ten Berg; A W J Van 't Hof
Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction.
Journal of thrombosis and haemostasis : JTH 2009;7(10):1612-8.
2009: B J L Van den Branden; Martijn C Post; Wybren Jaarsma; Jurriën M ten Berg; Maarten J Suttorp
New bioabsorbable septal repair implant for percutaneous closure of a patent foramen ovale: short-term results of a single-centre experience.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;74(2):286-90.
2009: Jochem W van Werkum; Jurriën M ten Berg; Albert J Bredenoord
Proton pump inhibitors and clopidogrel: a difficult dilemma.
American heart journal 2009;157(6):e43; author reply e45.
2009: H J Bouman; Jochem W van Werkum; C M Hackeng; N Clappers; Jurriën M ten Berg
Cangrelor increases the magnitude of platelet inhibition and reduces interindividual variability in clopidogrel-pretreated subjects.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2009;17(5):195-8.
2009: Jochem W van Werkum; Antonius A Heestermans; A Carla Zomer; Johannes C Kelder; Maarten J Suttorp; Benno J Rensing; Jacques J Koolen; B R Guus Brueren; Jan-Henk E Dambrink; Raymond W Hautvast; Freek W Verheugt; Jurriën M ten Berg
Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
Journal of the American College of Cardiology 2009;53(16):1399-409.
2009: Robert A Byrne; Stefanie Schulz; Julinda Mehilli; Raisuke Iijima; Steffen Massberg; Franz-Josef Neumann; Jurriën M ten Berg; Albert Schömig; Adnan Kastrati
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study.
American heart journal 2009;157(4):620-4.e2.
2009: Jochem W van Werkum; Antonius A C M Heestermans; Fleur I de Korte; Johannes C Kelder; Maarten J Suttorp; Benno J W M Rensing; Bastiaan Zwart; B R Guus Brueren; Jacques J Koolen; Jan-Henk E Dambrink; Arnoud W J van't Hof; Freek W A Verheugt; Jurriën M ten Berg
Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases.
Circulation 2009;119(6):828-34.
2008: A van der Laan; Alexander Hirsch; Robert J Nijveldt; Pieter A van der Vleuten; Willem J van der Giessen; Pieter A Doevendans; Johannes Waltenberger; Jurriën M ten Berg; Wim R M Aengevaeren; J J Zwaginga; B J Biemond; Albert C van Rossum; Jan G P Tijssen; Felix Zijlstra; Jan J Piek
Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2008;16(12):436-9.
2008: Jochem W van Werkum; A M Harmsze; E H A M Elsenberg; H J Bouman; Jurriën M ten Berg; Christian M Hackeng
The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence.
Platelets 2008;19(7):479-88.
2008: J G L M Luermans; Martijn C Post; H W M Plokker; Jurriën M ten Berg; Maarten J Suttorp
Complications and mid-term outcome after percutaneous patent foramen ovale closure in patients with cryptogenic stroke.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2008;16(10):332-6.
2008: Jochem W van Werkum; Jurriën M ten Berg; HW Thijs Plokker; Johannes C Kelder; Maarten Jan Suttorp; Benno J W M Rensing; Matthijs Tersmette
Staphylococcus aureus infection complicating percutaneous coronary interventions.
International journal of cardiology 2008;128(2):201-6.
2008: Jurriën M ten Berg; Jochem W van Werkum
Point-of-care platelet function testing in patients undergoing PCI: is it ready for use in clinical practice?
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2008;4 Suppl C():C72-4.
2008: Jochem W van Werkum; Jurriën M ten Berg
Platelet reactivity as a risk-factor for stent thrombosis: can this be one of the currently available appropriate methods to determine platelet reactivity?
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2008;4 Suppl C():C11-6.
2008: Fleur I de Korte; Jochem W van Werkum; Peter L M Vijverberg; Jurriën M ten Berg
Late coronary stent thrombosis complicating urologic surgery.
European urology 2008;54(1):221-5; quiz 225.
2008: Chris van der Lee; Bas Scholzel; Jurriën M ten Berg; Marcel L Geleijnse; Herman H Idzerda; Ron T van Domburg; Wim B Vletter; Patrick Washington Serruys; Folkert J Ten Cate
Usefulness of clinical, echocardiographic, and procedural characteristics to predict outcome after percutaneous transluminal septal myocardial ablation.
The American journal of cardiology 2008;101(9):1315-20.
2008: Alexander Hirsch; Robert J Nijveldt; Pieter A van der Vleuten; René A Tio; Willem J van der Giessen; Koen M J Marques; Pieter A Doevendans; Johannes Waltenberger; Jurriën M ten Berg; Wim R M Aengevaeren; Bart J Biemond; Jan G P Tijssen; Albert C van Rossum; Jan J Piek; Felix Zijlstra
Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2008;71(3):273-81.
2008: Gjin Ndrepepa; Adnan Kastrati; Julinda Mehilli; Franz-Josef Neumann; Jurriën M ten Berg; Olga Bruskina; Franz Dotzer; Melchior Seyfarth; Jürgen Pache; Josef Dirschinger; Peter B Berger; Albert Schömig
One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.
European heart journal 2008;29(4):455-61.
2008: Paul Knaapen; Tjeerd Germans; Paolo G Camici; Ornella E Rimoldi; Folkert J Ten Cate; Jurriën M ten Berg; Pieter A Dijkmans; Ronald Boellaard; Willem G Van Dockum; Marco J W Götte; Jos W R Twisk; Albert C van Rossum; Adriaan A Lammertsma; Frans C Visser
Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.
American journal of physiology. Heart and circulatory physiology 2008;294(2):H986-93.
2008: Jochem W van Werkum; Christian M Hackeng; Jaap Jan J Smit; Arnoud Wj Van't Hof; Freek Wa Verheugt; Jurriën M ten Berg
Monitoring antiplatelet therapy with point-of-care platelet function assays: a review of the evidence.
Future cardiology 2008;4(1):33-55.
2008: Antonius A C M Heestermans; Jochem W van Werkum; Dirk Taubert; Toine H Seesing; Nicolas von Beckerath; Christian M Hackeng; Edgar Schömig; F W A Verheugt; Jurriën M ten Berg
Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction.
Thrombosis research 2008;122(6):776-81.
2007: M J M Kurvers; R L Braam; J F Verzijlbergen; A A C M Heestermans; Jurriën M ten Berg
Myocardial salvage in STEMI patients treated with primary coronary angioplasty as demonstrated by myocardial SPECT.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2007;15(12):422-3.
2007: Arnoud W J van 't Hof; Christian Hamm; Saman Rasoul; Soneil Guptha; John F Paolini; Jurriën M ten Berg
Ongoing tirofiban in myocardial infarction evaluation (On-TIME) 2 trial: rationale and study design.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2007;3(3):371-80.
2007: Julinda Mehilli; Gjin Ndrepepa; Adnan Kastrati; Franz-Josef Neumann; Jurriën M ten Berg; Olga Bruskina; Franz Dotzer; Melchior Seyfarth; Jürgen Pache; Sebastian Kufner; Josef Dirschinger; Peter B Berger; Albert Schömig
Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial.
American heart journal 2007;154(1):158.e1-7.
2007: Jochem W van Werkum; M Kleibeuker; N Mieremet; Jurriën M ten Berg; Christian M Hackeng
Evaluation of the platelet response to clopidogrel with light transmittance aggregometry: peak aggregation or late aggregation?
Journal of thrombosis and haemostasis : JTH 2007;5(4):884-6.
2007: Jochem W van Werkum; Toine H Seesing; Maarten J Suttorp; Egbert T Bal; Peter den Heijer; Jurriën M ten Berg
Double-trouble: three cases with simultaneous stent thrombosis in different coronary arteries.
Journal of interventional cardiology 2007;20(2):132-5.
2007: Jochem W van Werkum; C A K van der Stelt; Toine H Seesing; Jurriën M ten Berg; Christian M Hackeng
The flow cytometric VASP assay can be used to determine the effectiveness of clopidogrel in patients treated with abciximab.
Journal of thrombosis and haemostasis : JTH 2007;5(4):881-3.
2007: Jochem W van Werkum; A A C M Heestermans; H W M Plokker; Jurriën M ten Berg
Clinical, biochemical and genetical resistance to clopidogrel in a patient with recurrent stent thrombosis.
International journal of cardiology 2007;116(1):136-7; author reply 134-5.
2007: Gerry P McCann; Willem G Van Dockum; Aernout M Beek; Robert J Nijveldt; Folkert J Ten Cate; Jurriën M ten Berg; Albert C van Rossum
Extent of myocardial infarction and reverse remodeling assessed by cardiac magnetic resonance in patients with and without right bundle branch block following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
The American journal of cardiology 2007;99(4):563-7.
2007: Jochem W van Werkum; Wim Gerritsen; Johannes C Kelder; Christian M Hackeng; Sjef M P G Ernst; Vera H M Deneer; Maarten J Suttorp; Benno J Rensing; H W M Plokker; Jurriën M ten Berg
Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2007;15(11):375-81.
2007: Jochem W van Werkum; Christian M Hackeng; F I de Korte; Freek W A Verheugt; Jurriën M ten Berg
Point-of-care platelet function testing in patients undergoing PCI: between a rock and a hard place.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2007;15(9):299-305.
2006: Willem G Van Dockum; Joost P A Kuijer; Marco J W Götte; Folkert J Ten Cate; Jurriën M ten Berg; Aernout M Beek; Jos W R Twisk; J Tim Marcus; Cees A Visser; Albert C van Rossum
Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis.
European heart journal 2006;27(23):2833-9.
2006: Gjin Ndrepepa; Adnan Kastrati; Julinda Mehilli; Franz-Josef Neumann; Jurriën M ten Berg; Olga Bruskina; Franz Dotzer; Melchior Seyfarth; Jürgen Pache; Josef Dirschinger; Kurt Ulm; Peter B Berger; Albert Schömig
Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions.
Circulation 2006;114(19):2040-6.
2006: Jochem W van Werkum; C A K van der Stelt; Toine H Seesing; Christian M Hackeng; Jurriën M ten Berg
A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention.
Journal of thrombosis and haemostasis : JTH 2006;4(11):2516-8.
2006: Maarten J Suttorp; Gert-Jan Laarman; Braim M Rahel; Johannes C Kelder; Mike A R Bosschaert; Ferdinand Kiemeneij; Jurriën M ten Berg; Egbert T Bal; Benno J Rensing; Frank D Eefting; E Gijs Mast
Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions.
Circulation 2006;114(9):921-8.
2006: A A C M Heestermans; Jochem W van Werkum; Edgar Schömig; Jurriën M ten Berg; Dirk Taubert
Clopidogrel resistance caused by a failure to metabolize clopidogrel into its metabolites.
Journal of thrombosis and haemostasis : JTH 2006;4(5):1143-5.
2006: Jochem W van Werkum; A A C M Heestermans; Wybren Jaarsma; R W M Hautvast; Menko Jan de Boer; Jurriën M ten Berg
[Thrombosis of a coronary stent after discontinuing treatment with clopidogrel].
Nederlands tijdschrift voor geneeskunde 2006;150(15):863-8.
2006: Adnan Kastrati; Julinda Mehilli; Franz-Josef Neumann; Franz Dotzer; Jurriën M ten Berg; Hildegard Bollwein; Isolde Graf; Maryam Ibrahim; Jürgen Pache; Melchior Seyfarth; Helmut Schühlen; Josef Dirschinger; Peter B Berger; Albert Schömig
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.
JAMA : the journal of the American Medical Association 2006;295(13):1531-8.
2006: Jochem W van Werkum; Antonius A C M Heestermans; Jurriën M ten Berg
Point-of-care devices for monitoring anti-platelet therapy.
Thrombosis research 2006;118(6):769-70.
2005: Albert Schömig; Claus Schmitt; Alban Dibra; Julinda Mehilli; Christian Volmer; Helmut Schühlen; Josef Dirschinger; Franz Dotzer; Jurriën M ten Berg; Franz-Josef Neumann; Peter B Berger; Adnan Kastrati
One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.
European heart journal 2005;26(14):1379-84.
2005: Willem G Van Dockum; Aernout M Beek; Folkert J Ten Cate; Jurriën M ten Berg; Olga Bondarenko; Marco J W Götte; Jos W R Twisk; Mark B M Hofman; Cees A Visser; Albert C van Rossum
Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
Circulation 2005;111(19):2503-8.
2004: David E Kandzari; Peter B Berger; Adnan Kastrati; Steven R Steinhubl; Julinda Mehilli; Franz Dotzer; Jurriën M ten Berg; Franz-Josef Neumann; Hildegard Bollwein; Josef Dirschinger; Albert Schömig
Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization.
Journal of the American College of Cardiology 2004;44(11):2133-6.
2004: B R G Brueren; J M P G Ernst; Maarten J Suttorp; Jurriën M ten Berg; Benno J Rensing; E Gijs Mast; Egbert T Bal; A Jacob Six; H W M Plokker
Emergency percutaneous coronary interventions for unprotected left main stenoses: immediate and long term follow up.
Heart (British Cardiac Society) 2004;90(9):1067-8.
2004: Braim M Rahel; Maarten J Suttorp; Jurriën M ten Berg; Egbert T Bal; Sjef M P G Ernst; Benno J Rensing; Johannes C Kelder; H W M Plokker
Cutting balloon for in-stent restenosis: acute and long-term results.
Journal of interventional cardiology 2004;17(4):197-201.
2004: Braim M Rahel; Maarten J Suttorp; Gert-Jan Laarman; Ferdinand Kiemeneij; Egbert T Bal; Benno J Rensing; Sjef M P G Ernst; Jurriën M ten Berg; Johannes C Kelder; H W M Plokker
Primary stenting of occluded native coronary arteries: final results of the Primary Stenting of Occluded Native Coronary Arteries (PRISON) study.
American heart journal 2004;147(5):e22.
2004: Adnan Kastrati; Julinda Mehilli; Helmut Schühlen; Josef Dirschinger; Franz Dotzer; Jurriën M ten Berg; Franz-Josef Neumann; Hildegard Bollwein; Christian Volmer; Meinrad Gawaz; Peter B Berger; Albert Schömig
A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.
The New England journal of medicine 2004;350(3):232-8.
2004: Willem G Van Dockum; Folkert J Ten Cate; Jurriën M ten Berg; Aernout M Beek; Jos W R Twisk; Jeroen Vos; Mark B M Hofman; Cees A Visser; Albert C van Rossum
Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging.
Journal of the American College of Cardiology 2004;43(1):27-34.
2003: B R G Brueren; J M P G Ernst; Maarten J Suttorp; Jurriën M ten Berg; Benno J Rensing; E Gijs Mast; Egbert T Bal; A Jacob Six; H W M Plokker
Long term follow up after elective percutaneous coronary intervention for unprotected non-bifurcational left main stenosis: is it time to change the guidelines?
Heart (British Cardiac Society) 2003;89(11):1336-9.
2003: Braim M Rahel; Maarten J Suttorp; Hans A Te Riele; Egbert T Bal; Sjef M P G Ernst; E Gijs Mast; Jurriën M ten Berg; Johannes C Kelder; H W M Plokker
Stenting for restenotic lesions with the BARD XT stent.
Journal of interventional cardiology 2003;16(3):227-30.
2003: Jurriën M ten Berg; Johannes C Kelder; Maarten J Suttorp; Freek W A Verheugt; H W M Plokker
A randomized trial assessing the effect of coumarins started before coronary angioplasty on restenosis: results of the 6-month angiographic substudy of the Balloon Angioplasty and Anticoagulation Study (BAAS).
American heart journal 2003;145(1):58-65.
2002: Jurriën M ten Berg; Wim Gerritsen; Fred J L M Haas; Johannes C Kelder; Freek W A Verheugt; HW Thijs Plokker
Pretreatment with oral anticoagulants decreases platelet activation in patients before and after percutaneous coronary intervention.
Thrombosis and haemostasis 2002;88(6):924-30.
2002: Braim M Rahel; Maarten J Suttorp; Jurriën M ten Berg; Egbert T Bal; Sjef M P G Ernst; E Gijs Mast; Johannes C Kelder; H W M Plokker
Is direct stent implantation without predilatation safe? Acute and long-term outcome.
Journal of interventional cardiology 2002;15(4):263-8.
2002: Karim Hamraoui; Sjef M P G Ernst; Pascal F H M van Dessel; Johannes C Kelder; Jurriën M ten Berg; Maarten J Suttorp; Wybren Jaarsma; Thijs H W Plokker
Efficacy and safety of percutaneous treatment of iatrogenic femoral artery pseudoaneurysm by biodegradable collagen injection.
Journal of the American College of Cardiology 2002;39(8):1297-304.
2002: B R G Brueren; Jurriën M ten Berg; Maarten J Suttorp; Egbert T Bal; J M P G Ernst; E Gijs Mast; H W M Plokker
How good are experienced cardiologists at predicting the hemodynamic severity of coronary stenoses when taking fractional flow reserve as the gold standard.
The international journal of cardiovascular imaging 2002;18(2):73-6.
2002: Jurriën M ten Berg; Wim Gerritsen; Fred J L M Haas; Hans C Kelder; Freek W A Verheugt; H W M Plokker
High-dose aspirin in addition to daily low-dose aspirin decreases platelet activation in patients before and after percutaneous coronary intervention.
Thrombosis research 2002;105(5):385-90.
2002: Jurriën M ten Berg; Johannes C Kelder; Thijs H W Plokker; Ben A van Hout
Costs and effectiveness of using coumarins before, during and after coronary angioplasty.
PharmacoEconomics 2002;20(12):847-53.
2001: J C Grutters; Jurriën M ten Berg; J van der Zeijden; Wybren Jaarsma; J M P G Ernst; C J Westermann
Patent foramen ovale causing position-dependent shunting in a patient, when laying down her corset.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2001;18(4):731-3.
2001: Jurriën M ten Berg; Johannes C Kelder; Maarten J Suttorp; Freek W A Verheugt; HW Thijs Plokker
Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study.
Journal of the American College of Cardiology 2001;38(4):1061-9.
2001: Jurriën M ten Berg; B A Hutten; Johannes C Kelder; Freek W A Verheugt; H W M Plokker
Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications.
Circulation 2001;103(16):2042-7.
2000: Jurriën M ten Berg; Johannes C Kelder; Maarten J Suttorp; E Gijs Mast; Egbert T Bal; Sjef M P G Ernst; Freek W A Verheugt; H W M Plokker
Effect of coumarins started before coronary angioplasty on acute complications and long-term follow-up: a randomized trial.
Circulation 2000;102(4):386-91.
1998: Jurriën M ten Berg; R van Tooren; Wybren Jaarsma; M J Suttorp; H W Plokker
Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms.
Journal of the American College of Cardiology 1998;32(5):1485.
1998: Jurriën M ten Berg; H W M Plokker
Effect of warfarin on rate of restenosis after PTCA.
Circulation 1998;97(20):2097-8.
1996: Jurriën M ten Berg; M T Gin; Sjef M P G Ernst; Johannes C Kelder; Maarten J Suttorp; E Gijs Mast; Egbert T Bal; H W M Plokker
Ten-year follow-up of percutaneous transluminal coronary angioplasty for proximal left anterior descending coronary artery stenosis in 351 patients.
Journal of the American College of Cardiology 1996;28(1):82-8.
1996: T Haitjema; Jurriën M ten Berg; T T Overtoom; J M P G Ernst; C J Westermann
Unusual complications after embolization of a pulmonary arteriovenous malformation.
Chest 1996;109(5):1401-4.
1996: Jurriën M ten Berg; Adriaan A Voors; Maarten J Suttorp; Sjef M P G Ernst; E Gijs Mast; Egbert T Bal; H W M Plokker
Long-term results after successful percutaneous transluminal coronary angioplasty in patients over 75 years of age.
The American journal of cardiology 1996;77(9):690-5.
1995: Jurriën M ten Berg; Wybren Jaarsma; R P Hamerlynck; Maarten J Suttorp
Rupture of the left coronary cusp of the aortic valve caused by blunt chest trauma: early diagnosis by transesophageal echocardiography.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 1995;8(5 Pt 1):766-9.
1994: Jurriën M ten Berg; Maarten J Suttorp; Paul J Knaepen; Sjef M P G Ernst; F E E Vermeulen; Wybren Jaarsma
Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy.
Circulation 1994;90(4):1781-5.
1992: Jurriën M ten Berg; H R Elbers; J J A M T Defauw; H W M Plokker
Endocarditis on a left atrial myxoma.
European heart journal 1992;13(11):1592-3.
1992: Jurriën M ten Berg; Egbert T Bal; T J Gin; J M P G Ernst; E Gijs Mast; Carl A P L Ascoop; J J A M T Defauw; H W M Plokker
Initial and long-term results of percutaneous transluminal coronary angioplasty in patients 75 years of age and older.
Catheterization and cardiovascular diagnosis 1992;26(3):165-70.